Latest filing published 02 Jul 2009 for GeoPharma, Inc., €183k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Jugal K. Taneja discloses dealings in 4 companies, chiefly GeoPharma, Inc., Vertical Health Solutions Inc and Drugmax Inc. We count 28 filings; the first trade dates from 30 July 2004 and the latest from 26 June 2009.
Market trades split into 6 purchases (€1.1B) and 1 sale (€23k). The net balance comes to €1.1B on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 share grants.
In size, the median ticket on the buying side is €82.0M.
The newest entry dates from 2 July 2009: a share grant of €183k, in GeoPharma, Inc. The last purchase on record was published on 23 October 2008, which is 6,575 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations